
New-generation Non-Invasive Prenatal Testing (NIPT) utilizes analysis of cell-free fetal DNA (cffDNA) in maternal blood to screen for common chromosomal aneuploidies and selected genetic conditions in the fetus.
For more information, you may download our newsletter below.